In Brief: FDA Office of Generic Drugs
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of Generic Drugs: Allen Rudman, PhD, appointed deputy director of OGD's Division of Chemistry I. He replaces Frank Holcombe, PhD, who left to become director of OGD's Division of Chemistry II on Aug. 5. Rudman has been an OGD chemistry reviewer since September 1991, FDA says, with 18 years prior experience in industry..